Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Antonio Garcia-Guerra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, University of Oxford, OX1 3PU Oxford, United Kingdom. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Guide, CRISPR-Cas Systems, Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Kennedy's Disease Association, Muscular Dystrophy Association.
Abstract (Originalsprache)
Nucleic acid nanostructures offer unique opportunities for biomedical applications due to their sequence-programmable structures and functions, which enable the design of complex responses to molecular cues. Control of the biological activity of therapeutic cargoes based on endogenous molecular signatures holds the potential to overcome major hurdles in translational research: cell specificity and off-target effects. Endogenous microRNAs (miRNAs) can be used to profile cell type and cell state, and are ideal inputs for RNA nanodevices. Here, we present CRISPR MiRAGE (miRNA-activated genome editing), a tool comprising a dynamic single-guide RNA that senses miRNA complexed with Argonaute proteins and controls downstream CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) activity based on the detected miRNA signature. We study the operation of the miRNA-sensing single-guide RNA and attain muscle-specific activation of gene editing through CRISPR MiRAGE in models of Duchenne muscular dystrophy. By enabling RNA-controlled gene editing activity, this technology creates opportunities to advance tissue-specific CRISPR treatments for human diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physics, University of Oxford, OX1 3PU Oxford, United Kingdom.
- Department of Paediatrics, University of Oxford, OX3 7TY Oxford, United Kingdom.
- Kavli Institute for Nanoscience Discovery, University of Oxford, OX1 3QU Dorothy Crowfoot Hodgkin Building, Oxford, United Kingdom.
- Institute of Developmental and Regenerative Medicine (IDRM), IMS-Tetsuya Nakamura Building, Old Road Campus, OX3 7TY Oxford, United Kingdom.
- Department of Molecular Therapy, National Institute of Neuroscience, National Centre of Neurology and Psychiatry, 187-8551 Tokyo, Japan.
- Department of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands.
ORCID-Profile: Pieter Vader, Carlo Rinaldi
Förderung
- Medical Research Council
- Kennedy's Disease Association
- Muscular Dystrophy Association
- Marie Curie Initial Training Network EScoDNA
- xford University Press John Fell Fund
- La Caixa Foundation Fellowship
- University of Oxford
- Kennedy’s Disease Association
Zitieren
APA
Garcia-Guerra, A., Sathyaprakash, C., de Jong, O. G., Lim, W. F., Vader, P., El Andaloussi, S., Bath, J., Reine, J., Aoki, Y., Turberfield, A. J., Wood, M. J. A., & Rinaldi, C. (2025). Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf016
Vancouver
Garcia-Guerra A, Sathyaprakash C, de Jong OG, Lim WF, Vader P, El Andaloussi S, et al. Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf016
BibTeX
@article{GarciaGuerra2025,
author = {Garcia-Guerra, Antonio and Sathyaprakash, Chaitra and de Jong, Olivier G and Lim, Wooi F and Vader, Pieter and El Andaloussi, Samir and Bath, Jonathan and Reine, Jesus and Aoki, Yoshitsugu and Turberfield, Andrew J and Wood, Matthew J A and Rinaldi, Carlo},
title = {Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf016}
}
EUVIMED